These differences may illustrate that TP53 mutation may affect the immune microenvironment of breast cancer to a certain extent (the specific mechanism is not clear here), this is consistent with the conclusion of a recent study (Liu Z et al., 2019). The gene discussed is TP53; the disease is breast carcinoma.